Impact of Rotavirus Vaccine Introduction for South Australian Children
|ClinicalTrials.gov Identifier: NCT01472575|
Recruitment Status : Unknown
Verified November 2011 by Associate Professor Helen Marshall, Women's and Children's Hospital, Australia.
Recruitment status was: Active, not recruiting
First Posted : November 16, 2011
Last Update Posted : November 16, 2011
Associate Professor Helen Marshall
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Associate Professor Helen Marshall, Women's and Children's Hospital, Australia
Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||December 2011|
|Estimated Study Completion Date :||December 2011|
|Submission Cycle||Results Submitted to ClinicalTrials.gov||Results Returned after Quality Control Review|
|1||August 25, 2014||September 4, 2014|
|2||September 8, 2014||September 15, 2014|
Clarke MF, Davidson GP, Gold MS, Marshall HS. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination. Vaccine. 2011 Jun 24;29(29-30):4663-7. doi: 10.1016/j.vaccine.2011.04.109. Epub 2011 May 14.